Almost 200 Covid-19 vaccine candidates are currently being developed. However, only a tiny percentage of these will ever be mass-produced and distributed. Concerns around ‘vaccine nationalism’ have grown, as high-income countries pre-order hundreds of millions of vaccine doses. This article looks at this problem and examines what solutions are being put in place to ensure low and middle income countries receive adequate supplies of any successful Covid-19 vaccine.